![cagrilintide phase 3 PDF] Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding 2 trial Novo Nordisk's cagrilintide shows promise](https://figures.semanticscholar.org/a9800c8f0dc40d6d18a09ab6d2f14e71a42af380/9-Figure3-1.png)
cagrilintide phase 3 PDF] Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding 2 trial Novo Nordisk's cagrilintide shows promise
Description
Semaglutide : Common side effects include nausea, vomiting, diarrhea, and constipation, particularly when starting treatment
![cagrilintide phase 3 PDF] Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding 2 trial Novo Nordisk's cagrilintide shows promise](https://media.licdn.com/dms/image/v2/D4E22AQF8M76CbCykfQ/feedshare-shrink_800/B4EZmlP3MjIIAg-/0/1759414024098?e=2147483647&v=beta&t=ADPpMQAMlkiCeduYBurP-uQwNX-TBOfgIq_FueChDvI)
Adopt a long-term mindset and combine shots with regular exercise, quality sleep, stress management, and ongoing provider support for meaningful, sustainable wellness results
![cagrilintide phase 3 PDF] Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding 2 trial Novo Nordisk's cagrilintide shows promise](https://lookaside.fbsbx.com/lookaside/crawler/threads/DNVL738ovhF/0/image.jpg)
Recombinant ESM1 has been shown to activate NF-B in HUVECs (68), and it is known that NF-B is downstream of PI3K/AKT (69)
![cagrilintide phase 3 PDF] Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding 2 trial Novo Nordisk's cagrilintide shows promise](https://cdn.sanity.io/images/0vv8moc6/patientcare/3f9da5ff66fe10bdc7b461ea87105923ef636ef9-392x653.jpg/amylin%20vs%20glp-1.JPG?w=392&max-h=653&fit=crop&auto=format)
The injection site may feel slightly sore, but this typically resolves within a day or two
![cagrilintide phase 3 PDF] Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding 2 trial Novo Nordisk's cagrilintide shows promise](https://www.thelancet.com/cms/10.1016/S2213-8587(25)00402-4/asset/7d856d37-1b1d-4481-9723-c6f28077488d/main.assets/gr2_lrg.jpg)
